RaDIANT Health Systems Intervention
Indiana University · with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Indiana University Health · NCT07033117
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–80 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 14000
- US sites recruiting
- 5
- Study start
- October 27, 2025
- Record last updated
- May 26, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The overarching goal of the proposed study is to determine whether the addition of structural interventions at the health system level targeting upstream barriers in the transplant process will improve access to transplant evaluation start.
Being studied: Performance Feedback Reports on Referral and Evaluation Closures; Dialysis Facility Awareness Campaign; Patient Contact via Preferred Method; Phone Call to Dialysis Facility During the Patient's Dialysis Session; Phone Call to Provider; Transplant Referral Communication Platforms or Email to Communicate Patient Status and No-Show; Audit and Tracking of Patient Contact Attempts Prior to Referral Closure
Conditions: End Stage Renal Disease (ESRD); Kidney Disease
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Five large transplant centers (Emory Transplant Center and Piedmont Transplant Center in Atlanta, GA; Medical University of SC; Duke University in Durham, NC; and Indiana University in Indianapolis, IN) \~800 referring dialysis center referring to these transplant centers
Exclusion Criteria
- Individuals referred, initiating evaluation, and waitlisted at non-participating start centers
Recruiting US locations
Piedmont Transplant Institute
Atlanta, GA 30309
Site contact: Ana Rossi, MD · (404) 605-4600 · ana.rossi@piedmont.org
Emory Transplant Center
Atlanta, GA 30322
Site contact: Stephen Pastan, MD · (855) 366-7989 · stephen.pastan@emoryhealthcare.org
IU Health Transplant - Indianapolis
Indianapolis, IN 46202
Site contact: Jonathan Fridell, MD · (317) 944-4370 · jfridell@iu.edu
Duke Transplant Center
Durham, NC 27710
Site contact: Goni Katz-Greenberg, MD · (855) 855-6484 · goni.katzgreenberg@duke.edu
MUSC Mid-Carolinas Transplant Center
Lancaster, SC 29720
Site contact: Prince Mohan, MD · (843) 792-5097 · mohanp@musc.edu
Similar studies in Georgia
All healthy volunteers studies in Georgia →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Influenza Human Challenge Model
Emory University
- Location
- Atlanta, GA + 1 other US site
- Eligibility basics
- Ages 18–49
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A/Texas Flu Challenge
Emory University
- Location
- Atlanta, GA + 1 other US site
- Eligibility basics
- Ages 18–49
- RecruitingHealthy volunteersPhase 1/Phase 2
A Study of BLB-201 RSV Vaccine in Infants and Children
Blue Lake Biotechnology Inc.
- Location
- Atlanta, GA + 13 other US sites
- Eligibility basics
- Ages 6 mo–5
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Decatur, GA + 49 other US sites
- Eligibility basics
- Ages 60+